The case for MDMA’s approval is riddled with problems
10 min
As researchers try to make sense of “open-label” placebos—fake drugs that proudly announce their fakeness—the mysterious effect is starting to show up beyond the world of medicine. Tom Vanderbilt reports on this phenomenon. Read by Mark Deakins.